SCHEMBL5773575

SCHEMBL5773575

Cc1cc(NC(=O)CCc2cnoc2-c2ccc(F)cc2)no1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 6/20 0.56
PKM P14618 2/20 0.52
NPC1 O15118 2/20 0.50
RAB9A P51151 1/20 0.50
KMT2A Q03164 5/20 0.49
MEN1 O00255 4/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C9 P11712 2/20 0.49
CYP2C19 P33261 1/20 0.49
HSD17B10 Q99714 2/20 0.46
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
CTSK P43235 1/20 0.46
KDM4E B2RXH2 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPK10 P53779 1/20 0.45
NPSR1 Q6W5P4 1/20 0.45
GAA P10253 2/20 0.45
EGFR P00533 1/20 0.45
LMNA P02545 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5776288 0.89 PKM (0.49) ALDH1A1PKMNPC1KMT2AMEN1
SCHEMBL5777386 0.80 LMNA (0.47) ALDH1A1KMT2AMEN1KDM4EGAA
SCHEMBL5776674 0.80 SMN1; SMN2 (0.46) NPC1RAB9AKMT2AMEN1KDM4E
SCHEMBL5769962 0.79 SMN1; SMN2 (0.41) ALDH1A1NPC1RAB9AKMT2AMEN1
SCHEMBL5774026 0.79 KDM4E (0.38) KDM4ELMNA
SCHEMBL5771249 0.78 RAB9A (0.51) ALDH1A1PKMNPC1RAB9AKMT2A
SCHEMBL5772947 0.77 MGLL (0.47) KMT2AMEN1GAA
SCHEMBL5773931 0.77 CYP11B1 (0.44) ALDH1A1KMT2AMEN1KDM4ELMNA
SCHEMBL5773415 0.76 MTNR1A (0.38) ALDH1A1KDM4ELMNASMN1; SMN2
SCHEMBL5773332 0.76 CNR2 (0.51) NPC1RAB9AKMT2AMEN1CYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060084690-A1 Isoxazole derivatives MOMOSE YU 2006-04-20 US disclosed
US-7022725-B2 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2006-04-04 US disclosed
US-20040048908-A1 Isoxazole derivatives TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2004-03-11 US disclosed
EP-1340749-A1 ISOXAZOLE DERIVATIVES Takeda Chemical Industries, Ltd. (JP) 2003-09-03 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060084690-A1 Isoxazole derivatives INSR, GPR119, INSRR ALDH1A1 1045/4885PKM 2534/4885NPC1 2417/4885
US-20040048908-A1 Isoxazole derivatives GPR119, INSR, IRS1 ALDH1A1 682/4885PKM 1824/4885NPC1 1770/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.